Scorpius Holdings Inc Asset Turnover Ratio (SCPX), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Scorpius Holdings inc   (SCPX)
 

Scorpius Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Scorpius Holdings Inc 's asset turnover ratio, the ratio that measures the ability of Scorpius Holdings Inc 's assets to generate revenue, sequentially decreased to 0.07 in the third quarter (Sep 30 2025), which does not come as a surprise, as the Scorpius Holdings Inc continue to experience difficult business climate.

Within sector 168 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2025 compared to the preceding quarter from 3070 to 3224.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SCPX Asset Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Asset Change -50.22 % -48.61 % -49.78 % -23.07 % -35.95 %
Y / Y Revenue Change -75.08 % -70.06 % -93.96 % -78.41 % 27.55 %
Asset Turnover Ratio (TTM) 0.07 0.08 0.08 0.15 0.23
SCPX's Total Ranking # 3224 # 3070 # 3236 # 1038 # 0
Seq. Asset Change -3.7 % -8.55 % -34.21 % -14.08 % -0.6 %
Seq. Revenue Change 1.01 % 7.19 % -79.72 % 13.49 % 21.37 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 169
Healthcare Sector # 483
Overall Market # 3224

Asset Turnover Ratio Statistics
High Average Low
0.18 0.08 0.01
(Dec 31 2018)   (Jun 30 2022)




SCPX Company Profile • Back to SCPX Efficiency Comparisons • Compare SCPX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Standard Biotools Inc   0.23 $ 129.758  Millions$ 572.136  Millions
Cue Biopharma Inc   0.22 $ 7.100  Millions$ 31.699  Millions
Lipocine Inc   0.22 $ 4.323  Millions$ 19.415  Millions
Arcus Biosciences Inc   0.22 $ 240.000  Millions$ 1,088.750  Millions
Hyperfine Inc   0.22 $ 10.885  Millions$ 49.756  Millions
Theravance Biopharma inc   0.21 $ 80.327  Millions$ 384.810  Millions
Maravai Lifesciences Holdings Inc   0.21 $ 191.308  Millions$ 928.538  Millions
Immunitybio inc   0.21 $ 82.555  Millions$ 401.939  Millions
Xoma Royalty Corporation  0.20 $ 47.106  Millions$ 230.159  Millions
Enanta Pharmaceuticals Inc  0.20 $ 65.324  Millions$ 320.352  Millions
Dariohealth Corp   0.20 $ 23.063  Millions$ 115.134  Millions
Zomedica Corp   0.20 $ 30.355  Millions$ 154.433  Millions
Coherus Oncology inc   0.19 $ 83.568  Millions$ 443.895  Millions
Biolife Solutions Inc   0.19 $ 74.005  Millions$ 393.487  Millions
Clearside Biomedical Inc   0.19 $ 3.329  Millions$ 17.942  Millions
Editas Medicine Inc   0.18 $ 46.384  Millions$ 254.393  Millions
Volitionrx Limited  0.18 $ 1.472  Millions$ 8.268  Millions
Syndax Pharmaceuticals Inc   0.18 $ 111.551  Millions$ 628.366  Millions
Petvivo Holdings Inc   0.18 $ 1.088  Millions$ 6.151  Millions
Alector Inc   0.18 $ 69.048  Millions$ 392.078  Millions
Moderna Inc   0.18 $ 2,232.000  Millions$ 12,747.750  Millions
Humacyte Inc   0.17 $ 22.958  Millions$ 132.682  Millions
Gossamer Bio Inc   0.17 $ 44.051  Millions$ 261.407  Millions
60 Degrees Pharmaceuticals Inc   0.17 $ 0.944  Millions$ 5.652  Millions
Xencor Inc  0.17 $ 150.132  Millions$ 901.217  Millions
Pacific Biosciences Of California Inc   0.16 $ 154.272  Millions$ 937.466  Millions
Cervomed Inc   0.16 $ 6.160  Millions$ 37.588  Millions
Arbutus Biopharma Corp  0.16 $ 14.606  Millions$ 89.765  Millions
Insmed Inc  0.16 $ 342.104  Millions$ 2,167.140  Millions
Maxcyte inc   0.15 $ 34.418  Millions$ 225.664  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.